Wednesday, September 2, 2020

Pick up in biosimilar launches driving Biocon's prospects; stock gains 7.8%

As US launch of Insulin addresses a large market, improved visibility for more launches will keep sentiment elevated

from Today's Paper https://ift.tt/3biXgrQ
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...